Optimizing cord blood sample cryopreservation

Cytotherapy

Volumn 14, Issue 3, 2012, Pages 359-365

  Harris, David T ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Cord blood; Cryopreservation; Cryovials; Plasma

Indexed keywords

HUMAN SERUM ALBUMIN; LIQUID NITROGEN;

ARTICLE; BACTERIOPHAGE PHI X 174; CELL VIABILITY; CONTAINER; CRYOBAG; CRYOPRESERVATION; CRYOVIAL; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; THERMOSTABILITY; UMBILICAL CORD BLOOD; VIRAL CONTAMINATION;

EID: 84856930818     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2011.638913     Document Type: Article

References (24)

1. Rocha V, Gluckman E. Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft-and transplantation-related factors. Br J Haematol. 2009;147: 262-74.
2. McGuckin C, Forraz N, Baradez MO, Navran S, Zhao J, Urban R, et al. Production of stem cells with embryonic characteristics from human umbilical cord blood. Cell Prolif. 2005;38:245-55. (Pubitemid 41176577)
3. McGuckin CP, Forraz N, Allouard Q, Pettengell R. Umbilical cord blood stem cells can expand hematopoietic and neuroglial progenitors in vitro. Exp Cell Res. 2004;295: 350-9. (Pubitemid 38490491)
4. Rogers I, Yamanaka N, Bielecki R, Wong CJ, Chua S, Yuen S, Casper RF. Identification and analysis of in vitro cultured CD45-positive cells capable of multi-lineage differentiation. Exp Cell Res. 2007;313:1839-52. (Pubitemid 46661846)
5. Kucia M, Halasa M, Wysoczynski M, Baskiewicz-Masiuk M, Moldenhawer S, Zuba-Surma E, et al. Morphological and molecular characterization of a novel population of CXCR4 + SSEA-4 + Oct-4 + very small embryonic-like cells purified from human umbilical cord blood-preliminary report. Leukemia. 2007;21:297-303. (Pubitemid 46158123)
6. Harris DT, He X, Badowski M, Nichols JC. Regenerative medicine of the eye: a short review. In: Levicar N, Habib NA, Dimarakis I, Gordon MY. Stem Cell Repair and Regeneration. Vol. 3. London: Imperial College Press; 2008. p. 211-25.
7. Copeland N, Harris D, Gaballa MA. Human umbilical cord blood stem cells, myocardial infarction and stroke. Clin Med. 2009:9:342-5.
8. Harris DT, Badowski M, Ahmad N, Gaballa M. The potential of cord blood stem cells for use in regenerative medicine. Expert Opin Biol Ther. 2008:7:1311-22.
9. Harris DT, Rogers I. Umbilical cord blood: a unique source of pluripotent stem cells for regenerative medicine. Curr Stem Cell Res Ther. 2007;2:301-9.
10. Harris DT. Non-haematological uses of cord blood stem cells. Br J Haematol. 2009;147:177-84.
11. Harris DT. Cord blood stem cells: a review of potential neurological applications. Stem Cell Rev. 2008:4:269-74.
12. Tedder RS, Zuckerman MA, Brink NS, Goldstone AH, Fielding A, Blair S, et al. Hepatitis B transmission from contaminated cryopreservation tank. Lancet. 1995;346:137-40.
13. Fountain D, Ralston M, Higins N, Gorlin JB, Uhl L, Wheeler C, et al. Liquid nitrogen freezers: a potential source of micro-bial contamination of hematopoietic stem cell components. Transfusion. 1997;37:585-91. (Pubitemid 27255827)
14. Harris DT, Schumacher MJ, Rychlik S, Booth A, Acevedo A, Rubinstein P, et al. Collection, separation and cryopreserva-tion of umbilical cord blood for use in transplantation. Bone Marrow Transplant. 1994:13:135-43. (Pubitemid 24059136)
15. Rubinstein P, Dobrila L, Rosenfield RE, Adamson JW, Migliac-cio G, Migliaccia AR, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA. 1995;92: 10119-22.
16. Fane BA, Hayashi M. Second-site suppressors of a cold-sensitive prohead accessory protein of bacteriophage fX174. Genetics. 1991;128:663-71.
17. Rowley SD. Hematopoietic stem cell cryopreservation: a review of current techniques. J Hematother. 1992;1:233-50.
18. AABB. Standards for Cellular Therapy Product Services. 4th ed. Bethesda, MD: AABB; 2009.
19. Rosenthal J, Brown H, Harris D. Stem cell recovery following implementation of an automated cord blood processing system in a high volume laboratory. Biol Blood Marrow Transplant. 2008;14:S42.
20. Querol S, Gomez SG, Pagliuca A, Torrabadella M, Madrigal JA. Quality rather than quantity: the cord blood bank dilemma. Bone Marrow Transplant. 2010;45:970-8.
21. Son JH, Heo YJ, Park MY, Kim HH, Lee KS. Optimization of cryopreservation condition for hematopoietic stem cells from umbilical cord blood. Cryobiology. 2010;60:287-92.
22. McCullough J, McKenna D, Kadidlo D, Schierman T, Wagner J. Issues in the quality of umbilical cord blood stem cells for transplantation. Transfusion. 2005;45:832-41. (Pubitemid 40798773)
23. Hubel A, Carlquist D, Clay M, McCullough J. Liquid storage, shipment, and cryopreservation of cord blood. Transfusion. 2004;44:518-25. (Pubitemid 38437587)
24. Campos L, Roubi N, Guyotat D. Definition of optimal conditions for collection and cryopreservation of umbilical cord hematopoietic cells. Cryobiology. 1995;32:511-15.